• Can changes in EEG improve neuropathic pain treatments - read Oct newsletter.
  • Nine posters ready to reveal at the SfN virtual conference 8-11 Nov, booth 1818.
  • Joined-up preclinical and clinical trials to advance psilocybin drug development
  • Transpharmation joins HaPpY team to help break the vicious cycle of chronic pain & mood disorders, see News for details
  • Announcing new premises in Poland with a focus on neuropsychiatric disorders...
  • New state-of-the-art premises at Discovery Park, Kent
 

News

News you can use

Transpharmation’s CEO Mark Duxon was pleased to speak with Guy Martin of The Pharma Letter about the impact of #Brexit on CROs. We have opened our fourth lab, most recently in Poland, and now with a footprint in the UK and continental Europe we are able to extend our services and partnerships to mitigate against border pressures, optimising opportunities for innovation and exciting collaborations.

Read the full interview here

 

Start a Conversation

preclinical +44 (0)203 633 2807

clinical trials +353 (0)1896 42 60

clinical research +48 515 244 120

EEG contact@transpharmation.co.uk


Copyright ©2021 Transpharmation Ltd. Website created by Identity Ipswich Web Design